Ayala Pharmaceuticals Inc (ADXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADXS | AMGN | GILD | BIIB | CELG |
| Company | Ayala Pharmaceuticals Inc | Amgen Inc | Gilead Sciences Inc | Biogen Inc | Celgene Corp |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.5350 | 313.39 | 65.51 | 215.30 | 108.01 |
| High | 0.5600 | 322.60 | 65.53 | 217.88 | 108.59 |
| Low | 0.5350 | 308.68 | 64.33 | 213.11 | 107.27 |
| Last | 0.5550 | 311.29 | 64.78 | 217.51 | 108.24 |
| Change | +0.0245 | +32.90 | -0.55 | +4.00 | +0.11 |
| % Change | +4.62% | +11.82% | -0.84% | +1.87% | +0.10% |
| Volume | 1,600 | 9,644,601 | 7,822,700 | 1,144,100 | 191,230,496 |
| 20-Day Average Volume | 2,815 | 2,646,885 | 7,406,455 | 1,344,250 | 16,188,930 |
| Previous Close | 0.5305 | 278.39 | 65.33 | 213.51 | 108.13 |
| Industry | Medical - Drugs | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | No |
| Technicals | |||||
| 20-Day Moving Average | 0.5996 | 272.27 | 66.88 | 203.10 | 108.17 |
| 20-Day Raw Stochastic | 27.50% | 81.73% | 8.01% | 95.41% | 63.25% |
| 20-Day Relative Strength | 44.79% | 72.10% | 30.11% | 56.41% | 64.69% |
| Weighted Alpha | -69.64 | +33.76 | -22.64 | -29.51 | +46.30 |
| Today's Opinion | 100% Sell | 24% Buy | 100% Sell | 56% Sell | 100% Buy |
| Previous Opinion | 88% Sell | 16% Sell | 100% Sell | 56% Sell | 100% Buy |
| Last Month's Opinion | 88% Sell | 24% Sell | 100% Sell | 100% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.91% since 04/25/24 | +15.30% since 04/26/24 | -0.98% since 04/26/24 | +4.12% since 04/26/24 | -1.97% since 11/13/19 |
| Low | 0.5190 on 05/02/24 | 268.99 on 04/29/24 | 64.33 on 05/03/24 | 208.54 on 04/29/24 | 107.27 on 11/20/19 |
| High | 0.6650 on 04/29/24 | 322.60 on 05/03/24 | 66.91 on 04/29/24 | 218.86 on 04/29/24 | 110.53 on 11/14/19 |
| 1-Month | |||||
| %Chg | -11.48% since 04/03/24 | +13.44% since 04/03/24 | -8.62% since 04/03/24 | +5.39% since 04/03/24 | +5.14% since 10/18/19 |
| Low | 0.5000 on 04/18/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 189.44 on 04/19/24 | 102.40 on 10/21/19 |
| High | 0.7000 on 04/05/24 | 322.60 on 05/03/24 | 71.39 on 04/04/24 | 218.86 on 04/29/24 | 110.70 on 11/13/19 |
| 3-Month | |||||
| %Chg | +1.00% since 02/02/24 | -3.68% since 02/02/24 | -15.83% since 02/02/24 | -10.75% since 02/02/24 | +13.63% since 08/20/19 |
| Low | 0.5000 on 04/18/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 189.44 on 04/19/24 | 93.41 on 08/23/19 |
| High | 1.4900 on 02/06/24 | 329.72 on 02/05/24 | 77.87 on 02/06/24 | 246.44 on 02/07/24 | 110.70 on 11/13/19 |
| 6-Month | |||||
| %Chg | -37.64% since 11/03/23 | +15.35% since 11/03/23 | -20.60% since 11/03/23 | -12.82% since 11/03/23 | +14.14% since 05/20/19 |
| Low | 0.5000 on 04/18/24 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 189.44 on 04/19/24 | 89.08 on 07/23/19 |
| High | 1.4900 on 02/06/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 268.30 on 01/03/24 | 110.70 on 11/13/19 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,967 | 166,968,480 | 80,656,088 | 31,668,802 | 77,035,920 |
| Shares Outstanding, K | 10,752 | 536,376 | 1,245,077 | 145,597 | 711,714 |
| Annual Sales | 10,000 | 28,190,000,000 | 27,116,000,000 | 9,835,600,000 | 15,281,000,000 |
| Annual Net Income | -48,070,000 | 6,717,000,000 | 5,665,000,000 | 1,161,100,000 | 4,046,000,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 6,686,000,000 | 2,290,500,000 | 4,520,000,000 |
| Last Quarter Net Income | -7,340,000 | 767,000,000 | -4,170,000,000 | 393,400,000 | 1,691,000,000 |
| 60-Month Beta | 1.63 | 0.60 | 0.22 | -0.01 | 1.41 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.96 on 04/16/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 3.67 on 04/24/24 | 2.99 on 10/31/19 |
| Latest Earnings Date | 02/19/24 | 05/02/24 | 04/25/24 | 04/24/24 | 10/31/19 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.94 | 16.21 | 14.23 | 10.99 |